Gilead cov khoom lag luam tau nce txog 4% tom qab sib qhia cov ntaub ntawv tshiab rau cov tshuaj mob qog noj ntshav

Shares ntawm Gilead Sciences Inc.
Tsiaj,
+ 5.16%
tau nce 4.9% hauv kev ua lag luam rau hnub Monday tom qab lub tuam txhab tau hais hauv xov xwm tshaj tawm tias Trodelvy tau txhim kho tag nrho cov ciaj sia nyob hauv cov neeg uas muaj HR + / HER2- mob qog noj ntshav ntawm lub mis metastatic. Gilead tau hais tias nws twb tau ua daim ntawv thov rau Food and Drug Administration nug tus tswj kom pom zoo Trodelvy rau pab pawg neeg mob no. Nws kuj tau hais tias nws cia siab tias yuav sai sai no yuav qhia tag nrho cov ntaub ntawv los ntawm qhov kev sim tshuaj no, uas yuav pab cov kws tshuaj ntsuam Wall Street nkag siab tias Trodelvy yuav sib tw li cas rau AstraZeneca's.
AZN,
+ 0.26%
Enhertu, raws li SVB Securities tus kws tshuaj ntsuam David Risinger. Trodelvy, uas tau pom zoo los kho tus mob qog noj ntshav ntawm lub mis triple-negative thiab mob qog noj ntshav urothelial hauv 2021, tau tsim txog $ 380 lab hauv kev muag khoom xyoo tas los. Raymond James tus kws tshuaj ntsuam Steven Seedhouse hais rau cov tub ua lag luam tias nws xav kom FDA pom zoo Trodelvy rau qhov kev qhia no tom qab kev tshuaj xyuas rau lub hlis. Gilead cov khoom lag luam poob qis 9.1% xyoo no, thaum qhov dav S&P 500
SPX,
+ 0.40%
tau poob 10.2%.